The store will not work correctly when cookies are disabled.
(R)-4-isobutyl-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,8]naphthyridine
ID: ALA4777852
PubChem CID: 134265727
Max Phase: Preclinical
Molecular Formula: C15H23N3
Molecular Weight: 245.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)Cc1ccnc2c1CC[C@@H]1CNCCN21
Standard InChI: InChI=1S/C15H23N3/c1-11(2)9-12-5-6-17-15-14(12)4-3-13-10-16-7-8-18(13)15/h5-6,11,13,16H,3-4,7-10H2,1-2H3/t13-/m1/s1
Standard InChI Key: FFLMKLHRNAKIDD-CYBMUJFWSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
40.7302 -12.0845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7291 -12.9040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4371 -13.3130 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.4353 -11.6756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1439 -12.0809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1473 -12.9061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5699 -12.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8529 -11.6631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5733 -12.9002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8574 -13.3116 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.8557 -14.1326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5682 -14.5486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.2840 -14.1373 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.2874 -13.3100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.2769 -12.4849 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
41.4329 -10.8584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1394 -10.4477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1369 -9.6305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8483 -10.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 8 1 0
6 10 1 0
9 7 1 0
7 8 1 0
9 10 1 0
9 14 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
9 15 1 1
4 16 1 0
16 17 1 0
17 18 1 0
17 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 245.37 | Molecular Weight (Monoisotopic): 245.1892 | AlogP: 2.00 | #Rotatable Bonds: 2 |
Polar Surface Area: 28.16 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.94 | CX LogP: 3.16 | CX LogD: 1.61 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.86 | Np Likeness Score: -0.18 |
References
1. Schrader TO,Zhu X,Kasem M,Ren A,Liu C,Wu C,Dang H,Le M,Gatlin J,Chase K,Frazer J,Whelan KT,Grottick AJ,Hutton C,Barden J,Chen C,Ortiz A,Feichtinger K,Semple G. (2021) Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT receptor., 38 [PMID:33636307] [10.1016/j.bmcl.2021.127872] |